🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thyroid cancer is a top cancer diagnosis for those aged 15-29! This September, learn more about the unique needs of the #AYA community during #ThyroidCancerAwarenessMonth. buff.ly/3R5tHB1 #KnowTheFacts #StayAware #thyroidcancer #thyroidcancerresearch

Did you know 19,000+ women in the U.S. will be diagnosed with #OvarianCancer this year, and nearly 13,000 will sadly lose the battle? This Ovarian Cancer Awareness Month, arm yourself with knowledge. Learn the symptoms and risks now: buff.ly/485gmOY #OC #OCSM

On the latest podcast, ACCRU's Dr. Toni Choueiri shines a light on the groundbreaking METEOR trial and the promising horizon of GU therapies. Tune in: buff.ly/40loRBZ #GUCancer #GenitourinaryCancer #METEORTrial #CancerInnovation Toni Choueiri, MD Tanios Bekaii-Saab, MD Matthew Goetz

National Hereditary Cancer Week is here. Get clarity on caring for those with genetic mutations linked to ovarian cancer from an expert OBGYN PA. Read the Q&A: buff.ly/3sJ1pCf #hereditarycancer #OvarianCancer #GeneticHealth #CancerCare #AskTheExpert #WomensHealth

Plug into our latest podcast episode and delve into the ACCRU neoadjuvant breast cancer trial, EVANGELINE. Our host chats with Dr. Matthew Goetz, Director of the Mayo Clinic Breast Cancer SPORE & Co-Leader of the Women's Cancer Program. buff.ly/3VbdytI #BCSM #BC

Vaccines and cancer recurrence: What's the connection? Tune in to our latest podcast, as Dr. Keith Knutson unpacks his pivotal work on immunotherapy for breast and ovarian cancers, striving for a relapse-free future after conventional treatments. buff.ly/3K2L9ih #BCSM #BC